Stocks · News reference
This Palantir Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Analysts upgraded Replimune, Madrigal, BBB Foods, Palantir, and Fomento Economico. See other opinions and price targets for these stocks.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
UBS Maintains Neutral on Fomento Economico, Lowers Price Target to $130
Madrigal Pharmaceuticals Publishes Data From Its Pre-Specified Secondary Analysis From Its Phase 3 MAESTRO-NASH Study In Journal Of Hepatology To Evaluate MASH Altered Patient Response To Rezdiffra
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced the publication of a
Palantir Technologies Stock Is Falling Friday: What's Going On?
Palantir stock drops over 7% to $186.36 despite a long-term bull trend. Read Cramer's $250 price target and key technicals.
The Stock Market Has Seen This Happen Only 2 Other Times in Over 150 Years, and History Has an Ominous Warning for Investors
The S&P 500's CAPE ratio has reached its second-highest level ever at above 40, a warning sign previously seen only before the Great Depression (1929) and dot-com bubble (2000). While renowned investors like Michael Burry and Ray Dalio warn of an AI bubble, the article advises against market timing, recommending consistent dollar-cost averaging into index ETFs instead, as historical data shows missing the market's best days significantly reduces returns.
Shares of software companies are trading lower amid a rotation out of technology and AI-related stocks. Rising inflation concerns and elevated oil prices are fueling expectations for further Fed tightening, while elevated borrowing costs could weigh on demand, valuations and debt metrics.